Literature DB >> 27744133

Repetitive nerve stimulation often fails to detect abnormal decrement in acute severe generalized Myasthenia Gravis.

Maarika Liik1, Anna Rostedt Punga2.   

Abstract

OBJECTIVE: We assessed the diagnostic pattern of repetitive nerve stimulation (RNS) test and concentric electrode (CNE) jitter analysis between patients with generalized myasthenia gravis (GMG) with acute versus slow onset.
METHODS: All examinations that established the diagnosis of GMG at the department of Clinical Neurophysiology, Uppsala University Hospital, were retrospectively analyzed from January 2012 to December 2014. Patients were grouped according to disease duration at neurophysiological evaluation: acute onset (<4weeks) or slow onset (⩾4weeks).
RESULTS: We identified 41 patients diagnosed with GMG. Of the nine patients with acute onset GMG (5 women) only one patient had abnormal decrement, whereas of the 32 patients with slow onset (13 women) 26 patients (84%) had abnormal decrement. CNE jitter was abnormal in all. AChR antibody status was comparable (78% versus 84%) whereas the MGFA class was higher in the acute onset group (range: 3A-5) compared to the slow onset group (range: 2A-3B).
CONCLUSIONS: RNS test is frequently normal in cases of acute severe GMG, including myasthenic crisis. Performing CNE jitter analysis is therefore of crucial importance for a correct early diagnosis. SIGNIFICANCE: MG patients with acute severe onset of bulbar or generalized fatigue often have normal findings on RNS test in proximal muscles.
Copyright © 2016 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CNE jitter; Decrement; Myasthenia gravis; Repetitive nerve stimulation

Mesh:

Year:  2016        PMID: 27744133     DOI: 10.1016/j.clinph.2016.09.012

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  3 in total

Review 1.  Giant cell myositis associated with concurrent myasthenia gravis: a case-based review of the literature.

Authors:  Frank A Scangarello; Luisa Angel-Buitrago; Melanie Lang-Orsini; Alexander Geevarghese; Knarik Arkun; Oscar Soto; Mithila Vullaganti; Robert Kalish
Journal:  Clin Rheumatol       Date:  2021-02-25       Impact factor: 2.980

2.  Nivolumab-induced myasthenia gravis in a patient with squamous cell lung carcinoma: Case report.

Authors:  Yu-Hsiu Chen; Feng-Cheng Liu; Chang-Hung Hsu; Chih-Feng Chian
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

3.  Diagnostic value of repeated ice tests in the evaluation of ptosis in myasthenia gravis.

Authors:  Jun Young Park; Hee Kyung Yang; Jeong-Min Hwang
Journal:  PLoS One       Date:  2017-05-31       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.